This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vetter Pharma can have €47m for new aseptic filling plant, EU says

( December 9, 2025, 10:45 GMT | Official Statement) -- MLex Summary: German company Vetter Pharma may receive a direct grant worth €47 million for a new plant to provide aseptic filling of injectable medicine into vials and syringes as a service for pharma companies. The measure will contribute to job creation, regional development and ensure affordable medicines, the European Commission said on Tuesday. The plant is in Saarlouis, southwestern Germany. Aseptic filling is a manufacturing process that maintains sterility when products are transferred to sterile containers.Statement follows. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections